Skip to content

LivaNova LIVN Change in AR

Change in AR at other companies

Abbott logo
AbbottABT
$42M-84.0%
Haemonetics logo
HaemoneticsHAE
$22.24M+315%
ITG
Integer HoldingsITGR
-$18.58M-202%
ResMed logo
ResMedRMD
$16.86M-57.9%
Boston Scientific logo
Boston ScientificBSX
$117M+9.3%
Stryker logo
StrykerSYK
-$444M-208%

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.32B+62.8%

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's change in AR?
LivaNova (LIVN) reported change in AR of $14.67M in Q1 2026.
How has LivaNova's change in AR changed year-over-year?
LivaNova's change in AR increased by 276.5% year-over-year, from $3.9M to $14.67M.
What is the long-term trend for LivaNova's change in AR?
Over 2 years (2021 to 2023), LivaNova's change in AR has grown at a 35.4% compound annual growth rate (CAGR), from $15.75M to $28.86M.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.